Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light
Open Access
- 31 October 2007
- journal article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 37 (2), 131-137
- https://doi.org/10.1016/j.transci.2007.07.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United StatesTransfusion, 2006
- Threats to blood safety posed by emerging protozoan pathogensVox Sanguinis, 2004
- Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistryTransfusion, 2004
- Trypanosoma cruziInactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UVAntimicrobial Agents and Chemotherapy, 2003
- Phenothiazine Radicals Inactivate Trypanosoma cruzi Dihydrolipoamide Dehydrogenase: Enzyme Protection by Radical ScavengersFree Radical Research, 2003
- Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmissionTransfusion, 2002
- American Trypanosomiasis (Chagas' Disease) -- A Tropical Disease Now in the United StatesThe New England Journal of Medicine, 1993
- Transfusion-Associated Trypanosoma cruzi Infection in a Non-Endemic AreaAnnals of Internal Medicine, 1989
- Transfusion-Associated Acute Chagas Disease Acquired in the United StatesAnnals of Internal Medicine, 1989
- The mitochondrion of Trypanosoma cruzi is a target of crystal violet toxicityMolecular and Biochemical Parasitology, 1989